Northern Trust
INBX

Northern Trust’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Northern Trust’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-307,541
Closed -$10.8M – 4534
2024
Q1 		$10.8M Sell
307,541
-6,348
-2% -$231K ﹤0.01% 1991
2023
Q4 		$11.9M Sell
313,889
-1,529
-0.5% -$32.8K ﹤0.01% 1938
2023
Q3 		$5.79M Sell
315,418
-13,579
-4% -$284K ﹤0.01% 2356
2023
Q2 		$8.54M Buy
328,997
+10,871
+3% +$254K ﹤0.01% 2175
2023
Q1 		$6M Buy
318,126
+6,139
+2% +$143K ﹤0.01% 2342
2022
Q4 		$7.69M Buy
311,987
+35,796
+13% +$1.05M ﹤0.01% 2188
2022
Q3 		$4.96M Buy
276,191
+16,012
+6% +$289K ﹤0.01% 2486
2022
Q2 		$2.95M Buy
260,179
+6,001
+2% +$88.3K ﹤0.01% 2845
2022
Q1 		$5.66M Sell
254,178
-7,051
-3% -$180K ﹤0.01% 2508
2021
Q4 		$11.4M Buy
261,229
+5,799
+2% +$232K ﹤0.01% 2140
2021
Q3 		$8.51M Buy
255,430
+9,593
+4% +$292K ﹤0.01% 2398
2021
Q2 		$6.77M Buy
245,837
+149,977
+156% +$3.12M ﹤0.01% 2638
2021
Q1 		$1.92M Sell
95,860
-3,340
-3% -$97.5K ﹤0.01% 3263
2020
Q4 		$3.27M Buy
+99,200
New +$2.64M ﹤0.01% 2925

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust's INBX Position: Q2 2024 in Review

Northern Trust sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 307,541 shares — an estimated $10.8M sold.

Northern Trust first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $11.9M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Northern Trust reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Northern Trust sold 307,541 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $10.8M.
  • Northern Trust first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Northern Trust's Inhibrx, Inc. Common Stock position peaked at $11.9M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.